Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union

Published:2018-09 Issue: Volume:16 Page:81-91
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Beletsi Alexandra,Koutrafouri Vassiliki,Karampli Eleftheria,Pavi Elpida

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference79 articles.

1. What is technology assessment?;Banta;Int J Technol Assess Health Care,2009

2. Reflections on the evolution of health technology assessment in Europe;Sorenson;Health Econ Policy Law,2012

3. Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems;Allen;Health Policy,2013

4. Role of centralized review processes for making reimbursement decisions on new health technologies in Europe;Stafinski;Clin Outcomes Res,2011

5. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems);Hutton;Int J Technol Assess Health Care,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience;International Journal of Environmental Research and Public Health;2024-09-03

2. The development of a roadmap for Health Technology Assessment implementation in Moldova;F1000Research;2024-05-20

3. Metric identification and mapping of reimbursable implant codes in Morocco to the global nomenclature (GMDN) and European (EUDAMED) of medical devices;Annales Pharmaceutiques Françaises;2024-05

4. Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies;BMC Cancer;2024-03-06

5. AOTMiT reimbursement recommendations compared to other HTA agencies;The European Journal of Health Economics;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3